Sending Office: Honorable Brian K. Fitzpatrick
Made In America Emergency Preparedness Act
Introduced by Rep. Brian Fitzpatrick with Reps. Anthony Brindisi,
Tom Reed, Josh Gottheimer, Will Hurd, Tom Suozzi, and Dean Phillips
Current cosponsors: Malinowski, Axne, McKinley, Rouda, and Allred
The COVID-19 crisis has shown us that we must do more, as a government and with private industry to prepare for the next national emergency. After 9/11, we as a nation said “Never Again”. In response to this current crisis, we must
never again find ourselves caught off-guard, unable to protect our communities. We should never again see 200,000 American lives at risk and day-to-day life turned upside down. This legislation focuses on ensuring our nation is taking the necessary steps
to mitigate the impacts of future national emergencies, improve responsiveness, and save lives.
To accomplish this, the legislation authorizes the creation of a National Commission on United States Preparedness for National Emergencies. This Commission is modeled on the 9/11 Commission, and will look at the national emergency response
by the United States government and private sector to this pandemic and provide a report to the President and Congress.
To ensure that our federal procurement supply chains are more self-sufficient and rely on more domestic sources of production, this bill also mandates that by 2025, federal agencies responsible for responding to national emergencies are procuring essential
supplies, like medication and personal protective equipment from domestic sources or manufacturing right here in the United States. DOD, DHS, HHS, CDC, and NIH would all have to meet this requirement. The Commission would provide a report and recommendations
to the President on which goods are essential to a response to a national emergency and must be manufactured in the United States by American owned businesses for procurement by these agencies.
To help incentivize businesses and manufacturers to come into compliance with the federal procurement requirements and encourage domestic production, this bill would allow immediate expensing for firms that incur costs associated with expanded pharmaceutical
or medical device manufacturing within the United States, including personal protective equipment and any other item determined by the National Commission on United States Preparedness for National Emergencies to be necessary.
If you have any questions or would like to cosponsor this legislation, please reach out to Mike McCabe at
Michael.McCabe@mail.house.gov or at 202.897.7861
Rep. Brian Fitzpatrick
e-Dear Colleague version 2.0